ARROWHEAD PHARMACEUTICALS, INC.
Industry: Life Sciences ・ $ARWR on Nasdaq
Insider Sale
+$573,240
-0.7%
Shares
Shares Volume: 26,712 Shares
Average Share Price: $21.46
INSIDER
Anzalone Christopher Richard
Chief Executive Officer (Director)
reported on Dec 20 2024
traded on Dec 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 3,788,335 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $772,349.89 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 1 / 21 |
| P/S VALUE RATIO | 0.009 |
| AVERAGE SALE VALUE | $454,847.7 |
| COMPANY PREVIOUS TRADES |